Exosomes secreted from mesenchymal stem cells help to increase the
number of regulatory T cells and prevent skin graft rejection in mice.
Tiny vesicles secreted by mesenchymal stem cells can modulate the immune
system and prevent the rejection of grafted tissue
Mesenchymal stem
cells (MSCs) can be extracted from many different types of tissues and are
currently used in clinical trials for a range of conditions, including
autoimmune diseases. Now, a team of researchers led by Sai Kiang Lim at the
A*STAR Institute of Medical Biology in Singapore has demonstrated that small
vesicles secreted by MSCs, called exosomes, can exert anti-inflammatory effects
on immune cells in tissue culture and also in mice that have received skin
transplants1.
Exosomes
contain a variety of proteins and other factors from their originating cells.
Previous studies have shown that MSC-derived exosomes protect heart tissue,
prompting Lim and colleagues to investigate whether MSC exosomes could have an
effect on immune cell function. The researchers isolated MSC exosomes but found
that they did not have a direct effect on the proliferation of lymphocytes — a
type of white blood cell — taken from the spleen. However, because lymphocyte
function is steered by monocytes, another type of white blood cell, the
researchers decided to further investigate whether MSC exosomes could activate
monocytes instead. They discovered that MSC exosomes reduced the expression of
pro-inflammatory factors and increased the expression of anti-inflammatory
factors in monocytes.
Toll-like
receptors on immune cells are proteins that initiate the immune response
following activation by many different factors, including one found in MSC
exosomes called fibronectic 1 (FN1). By blocking FN1 with an antibody, the
researchers were able to reduce the ability of MSC exosomes to activate
monocytes.
When
Lim and colleagues exposed the exosome-treated monocytes to developing T cells,
a type of lymphocyte, the cells matured into regulatory T (Treg)
cells — a cell type that suppresses the immune system. The findings suggest
that MSC exosomes probably act directly on monocytes, which can then modulate
lymphocyte maturation and function.
As a
result of their immunosuppressive properties, Treg cells can
help to prevent the rejection of skin grafts by the immune system. To test
whether MSC exosomes could facilitate the process, the researchers grafted skin
onto mice, and then treated some of the grafted mice with MSC exosomes.
Rejection of the grafted skin was delayed by a few days in the exosome-treated
mice compared to normal mice, probably due to the higher levels of Treg cells
in the exosome-treated mice.
“Our
findings suggest that MSC exosomes could be used to alleviate diseases that have
a dysfunctional immune component, such as lupus, psoriasis and sepsis,”
explains Lim. “A*STAR is currently funding the clinical development of MSC
exosomes,” he says.
The
A*STAR-affiliated researchers contributing to this research are from the Institute of Medical Biology and
the Bioprocessing Technology
Institute
Reference
- Zhang, B., Yin,
Y., Lai, R. C., Tan, S. S., Choo, A. B. H. & Lim, S. K. Mesenchymal
stem cells secrete immunologically active exosomes. Stem Cells and
Development 23, 1233–1244 (2014). | article
No comments:
Post a Comment